UK's BIA claims successful talks during business development mission to India

Members of the UK's BioIndustry Association (BIA) business development and membership services team has just returned from a busy and productive business mission to India, covering three of the main biotech and pharma hubs, Bangalore, Hyderabad and Mumbai. The five BIA members Antoxis, Chroma Therapeutics, Ionscope, Karus Therapeutics and Stabilitech met with over 60 Indian companies during the week long mission.

Simon Kerry, chief executive of Karus, commented: "The trade mission was an excellent opportunity to meet Indian companies that otherwise we would not have been able to do. India has a growing life-science sector with a reputation for excellence in preclinical and clinical development, but harnessing this expertise has, to date, been the preserve of large, international pharmaceutical companies. Cash constrained, smaller pharma and biotech companies also need to access these skills to remain competitive, and the trade mission provided not only an ideal introduction to the life-science sector in India but also specific contacts that will be of value to Karus in the coming months"

Budget changes welcome for the life sciences sector, but are not revolutionary